# US 2025/0026074 A1 · 3d-printing engineered living materials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0026074 A1
- Document ID: US20250026074A1
- Status: Published application
- Kind: A1
- Application number: 18/707,400
- Filed: 2022-11-04
- Published: 2025-01-23
- Earliest claimed: 2021-11-04
- Assignees: The Trustees of Princeton University
- Applicants: The Trustees of Princeton University
- Inventors: Sujit S. DATTA; Rodney PRIESTLEY; Xiaohui XU; Reed Konane BAY
- Web page: https://patentgrep.com/patent/US20250026074A1

## CPC

- B29C 64/106: using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material
- B29C 64/40: Structures for supporting 3D objects during manufacture and intended to be sacrificed after completion thereof
- B33Y 10/00: Processes of additive manufacturing
- B33Y 30/00: Apparatus for additive manufacturing; Details thereof or accessories therefor
- B33Y 70/10: Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials
- C08J 3/075: Macromolecular gels
- C12M 25/14: {Scaffolds; Matrices (in general C12N5/0068)}
- C12M 33/00: {Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus (chemical or physical laboratory apparatus in general B01L, devices for taking cell samples A61B10/0045, withdrawing or distributing predetermined quantities of fluid B01L99/00)}
- C12N 1/20: Bacteria; Culture media therefor
- C12N 11/14: Enzymes or microbial cells immobilised on or in an inorganic carrier
- B29C 64/10: Processes of additive manufacturing
- B29K 2033/26: {Polymers of acrylamide or methacrylamide}
- B29K 2105/0005: {containing compounding ingredients (releasing, lubricating or separating agents B29C33/56, fibers B29K2105/08, B29K2105/12; fillers B29K2105/16, recycled material B29K2105/26)}
- C08J 2333/26: Homopolymers or copolymers of acrylamide or methacrylamide
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS

## Abstract

Disclosed is a method to 3D print materials with defined bacterial communities into controlled, complex 3D structures, and compositions. The technique includes first providing an ink composition that includes a pre-polymer composition and a microorganism, where the pre-polymer composition includes a polymerizable monomer, a cross-linking agent, the photoinitiator, and a solvent. The technique also includes 3D printing a pattern in a hydrogel support matrix using the ink composition where the hydrogel support matrix is in a container. The technique may also include forming a 3D printed engineered living material by curing the 3D printed pattern.

## Claims

### Claim 1

A method for 3D printing engineered living materials, comprising:
providing an ink composition comprising a pre-polymer composition and a microorganism, the pre-polymer composition comprising a polymerizable monomer, a cross-linking agent, a photoinitiator, and a solvent;
3D printing a pattern in a hydrogel support matrix using the ink composition, the hydrogel support matrix being in a container; and
forming a 3D printed engineered living material by curing the 3D printed pattern.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the microorganism is a species of E. coli, A. adeninivorans, S. cerevisiae, C. glutamicum, or a combination thereof.

### Claim 3 (depends on 1)

The method according to claim 1, wherein providing the ink composition comprises:
forming an ink composition by mixing a pellet having a known cell amount with a pre-polymer composition;
centrifuging the ink composition; and
loading the centrifuged ink composition into a container for injection.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the container for injection is a syringe.

### Claim 5 (depends on 3)

The method according to claim 3, wherein the pellet is formed by:
inoculating cells of the microorganism into a growth medium;
growing the inoculated cells in the growth medium; and
centrifuging the grown cells into a pellet.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the polymerizable monomer is acrylamide.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the cross-linking agent is N,N′-methylenebis(acrylamide).

### Claim 8 (depends on 1)

The method according to claim 1, wherein the photoinitiator is 2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone.

### Claim 9 (depends on 1)

The method according to claim 1, further comprising forming the pre-polymer composition by mixing the polymerizable monomer, the cross-linking agent, the photoinitiator, and the solvent.

### Claim 10 (depends on 9)

The method according to claim 9, further comprising mixing a thickening agent into the pre-polymer composition.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the thickening agent is sodium alginate.

### Claim 12 (depends on 1)

The method according to claim 1, further comprising forming a hydrogel support matrix by:
forming a hydrogel composition by mixing a sterile growth medium with a thickening agent;
eliminating bubbles by centrifuging the hydrogel composition; and
loading the hydrogel composition into a container for printing into.

### Claim 13 (depends on 1)

The method according to claim 1, wherein curing the 3D printed pattern comprises irradiating the 3D printed pattern with at least one wavelength of light configured to activate the photoinitiator.

### Claim 14 (depends on 1)

The method according to claim 1, further comprising reducing a viscosity of the hydrogel matrix to allow the 3D printed engineered living material to be released from the matrix.

### Claim 15 (depends on 14)

The method according to claim 14, wherein reducing the viscosity of the hydrogel matrix comprises contacting at least part the hydrogel matrix with a buffered solution.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the buffered solution is 10× phosphate buffered solution.

### Claim 17

A system for 3D printing engineered living materials, comprising:
a container comprising a hydrogel support matrix;
a reservoir containing an ink, the ink comprising a pre-polymer composition and a microorganism, the pre-polymer composition comprising a polymerizable monomer, a crosslinking agent, a photoinitiator, and a solvent;
a print head configured to deposit ink from the reservoir into the hydrogel support matrix;
a light source configured to irradiate the deposited ink with at least one wavelength of light capable of activating the photoinitiator; and
a processor configured to control the print head and light source.

### Claim 18 (depends on 17)

The system according to claim 17, wherein the print head comprises an injection needle, the injection needle having a gauge between 15 and 34.
